Advitam Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-07-2024
- Paid Up Capital ₹ 0.50 M
as on 16-07-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Revenue 55.57%
(FY 2021)
- Profit 43.52%
(FY 2021)
- Ebitda 66.61%
(FY 2021)
- Net Worth 79.96%
(FY 2021)
- Total Assets 94.30%
(FY 2021)
About Advitam Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Neelam Bagwar, Rakesh Kumar, Astha Munjal, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909DL2016PTC307742
- Company No.
307742
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Oct 2016
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Advitam Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neelam Bagwar  | Director | 31-Oct-2016 | Current |
| Rakesh Kumar | Director | 31-Oct-2016 | Current |
| Astha Munjal | Director | 31-Oct-2016 | Current |
| Sudhakar Arya | Director | 31-Oct-2016 | Current |
Financial Performance of Advitam Life Sciences.
Advitam Life Sciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 55.57% increase. The company also saw a substantial improvement in profitability, with a 43.52% increase in profit. The company's net worth Soared by an impressive increase of 79.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advitam Life Sciences?
In 2021, Advitam Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aycertis Lifesciences Private LimitedInactive For E-Filing 7 months 22 daysNeelam Bagwar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advitam Life Sciences?
Unlock and access historical data on people associated with Advitam Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advitam Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advitam Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
